A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate

Author(s)

Lobba, Aline R. M. ; Alvarez-Flores, Miryam Paola ; Fessel, Melissa Regina ; Buri, Marcus Vinicius ; Oliveira, Douglas S. S. ; Gomes, Renata N. N. ; Cunegundes, Priscila S. S. ; DeOcesano-Pereira, Carlos ; Cinel, Victor D. D. ; Chudzinski-Tavassi, Ana M. M.

• Document type: Journal article
• Source: FRONTIERS IN MOLECULAR BIOSCIENCES; v. 9, p. 16-pg., 2022-08-16.

Abstract

Salivary glands are vital structures responsible for successful tick feeding. The saliva of ticks contains numerous active molecules that participate in several physiological processes. A Kunitz-type factor Xa (FXa) inhibitor, similar to the tissue factor pathway inhibitor (TFPI) precursor, was identified in the salivary gland transcriptome of Amblyomma sculptum ticks. The recombinant mature form of this Kunitz-type inhibitor, named Amblyomin-X, displayed anticoagulant, antiangiogenic, and antitumor properties. Amblyomin-X is a protein that inhibits FXa in the blood coagulation cascade and acts via non hemostatic mechanisms, such as proteasome inhibition. Amblyomin-X selectively induces apoptosis in cancer cells and promotes tumor regression through these mechanisms. Notably, the cytotoxicity of Amblyomin-X seems to be restricted to tumor cells and does not affect non-tumorigenic cells, tissues, and organs, making this recombinant protein an attractive molecule for anticancer therapy. The cytotoxic activity of Amblyomin-X on tumor cells has led to vast exploration into this protein. Here, we summarize the function, action mechanisms, structural features, pharmacokinetics, and biodistribution of this tick Kunitz-type inhibitor recombinant protein as a promising novel antitumor drug candidate. (AU)

• FAPESP's process: 20/13139-0 - Centre of Excellence in New Target Discovery
• Grantee: Ana Marisa Chudzinski-Tavassi
• Support Opportunities: Research Grants - Applied Research Centers Program
• FAPESP's process: 18/20469-7 - Several studies have shown that chondrocyte aging is associated with the degeneration of articular cartilage, and can be observed in joint diseases pathogenesis, such as rheumatoid arthritis and osteoarthritis (OA). one of the most prominent changes in
• Grantee: Renata Nascimento Gomes
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• FAPESP's process: 13/07467-1 - CeTICS - Center of Toxins, Immune-Response and Cell Signaling
• Grantee: Hugo Aguirre Armelin
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
• FAPESP's process: 18/10937-3 - Satellite cells: effects of lipocalin, hemolin and derived peptides on proliferation and differentiation of quiescent skeletal muscle cells
• Grantee: Angela María Alvarez Gómez
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• FAPESP's process: 15/50040-4 - Rational approach for searching molecular targets involved in inflammatory events and cell survival
• Grantee: Ana Marisa Chudzinski-Tavassi
• Support Opportunities: Research Grants - Applied Research Centers Program